Literature DB >> 1864600

High prevalence of aspartylglycosaminuria among school-age children in eastern Finland.

T Mononen1, I Mononen, R Matilainen, E Airaksinen.   

Abstract

A high prevalence of the lysosomal storage disease aspartylglycosaminuria was found in a study of four birth cohorts of 12882 children in eastern Finland. Using school achievement tests and registers of mentally retarded individuals, 178 mentally retarded children were identified. Randomized urine samples from 151 of the 178 retarded children and from 101 healthy children were analyzed quantitatively for aspartylglucosamine by high-performance liquid chromatography. The results identified three affected individuals in the retarded group indicating an exceptionally high prevalence of aspartylglycosaminuria (1:3643) in the study population, consistent with a carrier frequency of 1:30. The 95% confidence limits for the prevalence are 1:4 352-1:16389. This is the highest prevalence described for any glycoproteinosis in any population and comparable to the incidence figures of the most common lysosomal storage diseases, Gaucher disease type I and Tay-Sachs disease among Ashkenazi Jews. In the study group, aspartylglycosaminuria was, after trisomy 21 (n = 19) and the fragile X syndrome (n = 6), the most common genetic cause for mental retardation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864600     DOI: 10.1007/bf00200902

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  9 in total

1.  Cystic fibrosis in Finland: a molecular and genealogical study.

Authors:  J Kere; R Norio; E Savilahti; X Estivill; A de la Chapelle
Journal:  Hum Genet       Date:  1989-08       Impact factor: 4.132

2.  Aspartylglucosamine excretion in heterozygous carriers of aspartylglycosaminuria.

Authors:  T K Mononen
Journal:  Clin Chim Acta       Date:  1989-03-15       Impact factor: 3.786

3.  Population cytogenetics of folate-sensitive fragile sites. II. Autosomal rare fragile sites.

Authors:  M Kähkönen; C Tengström; T Alitalo; R Matilainen; M Kaski; E Airaksinen
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

Review 4.  Aspartylglycosaminuria. Analysis of thirty-four patients.

Authors:  S Autio
Journal:  J Ment Defic Res       Date:  1972

Review 5.  Hereditary diseases in Finland; rare flora in rare soul.

Authors:  R Norio; H R Nevanlinna; J Perheentupa
Journal:  Ann Clin Res       Date:  1973-06

6.  Liquid-chromatographic detection of aspartylglycosaminuria.

Authors:  T Mononen; M Parviainen; I Penttilä; I Mononen
Journal:  Clin Chem       Date:  1986-03       Impact factor: 8.327

7.  Prevalence of the fragile X syndrome in four birth cohorts of children of school age.

Authors:  M Kähkönen; T Alitalo; E Airaksinen; R Matilainen; K Launiala; S Autio; J Leisti
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

8.  Laboratory detection of aspartylglycosaminuria.

Authors:  I Mononen; V Kaartinen; T Mononen
Journal:  Scand J Clin Lab Invest Suppl       Date:  1988

9.  Assay of aspartylglycosylaminase by high-performance liquid chromatography.

Authors:  V Kaartinen; I Mononen
Journal:  Anal Biochem       Date:  1990-10       Impact factor: 3.365

  9 in total
  8 in total

Review 1.  Disease gene mapping in isolated human populations: the example of Finland.

Authors:  A de la Chapelle
Journal:  J Med Genet       Date:  1993-10       Impact factor: 6.318

2.  Crystallographic snapshot of a productive glycosylasparaginase-substrate complex.

Authors:  Yeming Wang; Hwai-Chen Guo
Journal:  J Mol Biol       Date:  2006-09-26       Impact factor: 5.469

3.  Single base deletion in exon 7 of the glycosylasparaginase gene causes a mild form of aspartylglycosaminuria in a patient of Mauritian origin.

Authors:  H Park; M Rossiter; A H Fensom; B Winchester; N N Aronson
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  Characterization of three alleles causing aspartylglycosaminuria: two from a British family and one from an American patient.

Authors:  H Park; M B Vettese; A H Fensom; K J Fisher; N N Aronson
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

5.  Chromosomal localization of the human glycoasparaginase gene to 4q32-q33.

Authors:  C Morris; N Heisterkamp; J Groffen; J C Williams; I Mononen
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

6.  Brain MRI findings in two Turkish pediatric patients with aspartylglucosaminuria.

Authors:  Ayşe Kartal; Kürşad Aydın
Journal:  Neuroradiol J       Date:  2016-08-22

Review 7.  Aspartylglycosaminuria: a review.

Authors:  Maria Arvio; Ilkka Mononen
Journal:  Orphanet J Rare Dis       Date:  2016-12-01       Impact factor: 4.123

8.  Functional Analysis of the Ser149/Thr149 Variants of Human Aspartylglucosaminidase and Optimization of the Coding Sequence for Protein Production.

Authors:  Antje Banning; Jan F König; Steven J Gray; Ritva Tikkanen
Journal:  Int J Mol Sci       Date:  2017-03-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.